Skip to Main Content
TRC_PL_NEW
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Journal Club
  • Podcasts
  • Drug Charts
    • Antidepressants
    • Contraceptives
    • Diabetes Drugs
    • Do Not Crush List
    • First Time Generics
    • New Drugs
    • More Charts >
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! RxAdvanced: Diabetes Monitoring & Management program provides pharmacists with the skills needed to effectively advise patients and clinicians on how to use technology and pattern management to achieve improved glycemic control. Learn More.
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment

Treatment

  • Diabetes (905)
    • Blood Glucose Meters (9)
    • Complications (203)
    • Diabetes in Pregnancy (12)
    • Diabetes Meds (86)
    • Drug-Induced Hypo/Hyperglycemia (140)
    • Monitoring (140)
    • Natural Medicines/Supplements (12)
    • Prevention (47)
    • Treatment (376)
      • Alpha-Glucosidase Inhibitors (27)
      • Amylin Agonist (20)
      • Bromocriptine (10)
      • Combination Products (23)
      • Gliptins (85)
      • Glitazones (129)
      • GLP-1 (41)
      • Incretin Enhancers/Mimetics (82)
      • Insulin (197)
      • Meglitinides (46)
      • Metformin (165)
      • SGLT2 Inhibitors (91)
      • Sulfonylureas (131)
      • Treatment of Pediatric Metabolic Syndrome (10)
  • Endocrinology (10)
  • Hyperglycemia (39)
  • Hypoglycemia (19)
  • Other (31)
  • Prediabetes (5)
  • Resources (277)
  • Thyroid Disorders (64)
271 - 285 of 376 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Guideline: Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012) June 2012
Article: Bydureon (by-DUR-ee-on), a new long-acting form of Byetta (exenatide) for type 2 diabetes March 2012
PL Voices: New Once WEEKLY Exenatide (Bydureon) March 2012
Article: Byetta WITH Lantus for type 2 diabetes December 2011
Commentary: Using Exenatide (Byetta) with Insulin Glargine (Lantus) December 2011
Article: You'll hear claims that gliptins (Januvia, etc) decrease cardiovascular risk in diabetes patients November 2011
Commentary: Diabetes Meds and Cardiovascular Risk November 2011
Article: confusing the news about Avandia and Actos July 2011
Article: how to manage diabetes during fasting July 2011
Commentary: Actos (Pioglitazone) and Increased Risk of Bladder Cancer July 2011
Article: Tradjenta (TRAD-gen-ta), a new gliptin for type 2 diabetes June 2011
Commentary: New Drug: Tradjenta (Linagliptin) June 2011
Guideline: Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy (2009) June 2011
Article: when to use metformin or pioglitazone for polycystic ovary syndrome (PCOS) May 2011
Commentary: Metformin vs Pioglitazone for Polycystic Ovary Syndrome May 2011
  • « Prev
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved